Home

Deerfield Special Situations Fund International LTD

CIK 1354397 · last filed 2013-01-15

Deerfield Special Situations Fund International LTD is a corporate insider who has filed 12 SEC Form 4 insider transactions across 6 companies since 2008. Across all open-market trades the lifetime net is +$192.1M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $64.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$64.07M

Companies

6

Total Filings

12

Lifetime Open-Market Net

$192.14M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RIGL 10%+ Owner 292,774 $38.50 $11.27M -$407.5K 1 2010-11-05
NeuroMetrix, Inc. (NURO) Delisted 10%+ Owner 10 $4.58 $46 -$4.08M 2 2010-09-23
NxStage Medical, Inc. (NXTM) Delisted 10%+ Owner 736,018 — — -$806.9K 1 2009-06-19
NITROMED INC (NTMD) Delisted 10%+ Owner 46,085,133 — — $196.53M 2 2009-04-27
DUSA 10%+ Owner 915,421 $57.68 $52.80M $1.51M 1 2009-03-13
Bio Green Med Solution, Inc. (CYCCP) Delisted 10%+ Owner 881,743 $5.05 $4.45M -$607.0K 1 2008-11-20

Recent Filings

12 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2013-01-15 — Grant (A) — $0
2012-07-03 — Mixed −6,383,398 -$8.08M
2011-09-28 — Sell (S) −52,500 -$52.5K
2010-11-05 RIGL Sell (S) −53,977 -$407.5K EDGAR
2010-09-23 NeuroMetrix, Inc. (NURO) Delisted Sell (S) −269,095 -$158.4K EDGAR
2010-08-23 NeuroMetrix, Inc. (NURO) Delisted Sell (S) −5,029,435 -$3.93M EDGAR
2009-07-01 — Sell (S) −1,376,565 -$8.08M
2009-06-19 NxStage Medical, Inc. (NXTM) Delisted Sell (S) −135,390 -$806.9K EDGAR
2009-04-27 NITROMED INC (NTMD) Delisted Mixed +205,103,085 $176.08M EDGAR
2009-03-13 DUSA Buy (P) +1,250,000 $1.51M EDGAR
Showing 1–10 of 12
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.